UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050996
Receipt number R000058134
Scientific Title Elucidation of pathomechanisms of delirium by EEG analysis: a cross-sectional study
Date of disclosure of the study information 2023/08/31
Last modified on 2023/10/10 15:45:03

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Elucidation of pathomechanisms of delirium by EEG analysis: a cross-sectional study

Acronym

Epileptic EEG activity in delirium

Scientific Title

Elucidation of pathomechanisms of delirium by EEG analysis: a cross-sectional study

Scientific Title:Acronym

Epileptic EEG activity in delirium

Region

Japan


Condition

Condition

delirium

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Hypothesis to be tested: Might part of delirium involve paroxysms of the temporal lobe as a pathomechanism?

Basic objectives2

Others

Basic objectives -Others

Exploration of pathomechanisms

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Prevalence of paroxysms (interictal period) on EEG in patients with delirium

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with delirium as defined by the DSM-5

Key exclusion criteria

Patients other than delirium

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Kotaro
Middle name
Last name Hatta

Organization

Juntendo University Nerima Hospital

Division name

Department of Psychiatry

Zip code

177-8521

Address

3-1-10 Takanodai, Nerima-ku, Tokyo

TEL

+81-3-5923-3111

Email

khatta@juntendo.ac.jp


Public contact

Name of contact person

1st name Kotaro
Middle name
Last name Hatta

Organization

Juntendo University Nerima Hospital

Division name

Department of Psychiatry

Zip code

177-8521

Address

3-1-10 Takanodai, Nerima-ku, Tokyo

TEL

+81-3-5923-3111

Homepage URL


Email

khatta@juntendo.ac.jp


Sponsor or person

Institute

Juntendo University

Institute

Department

Personal name

Kotaro Hatta


Funding Source

Organization

Japan Society for the Promotion of Science (JSPS KAKENHI)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Nippon Medical School Musashikosugi Hospital, Tokyo Medical and Dental University, Hiroshima City Hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Juntendo University Institutional Review Board

Address

2-1-1 Hongo, Bunkyo-ku, Tokyo

Tel

03-3814-5672

Email

jcrtc_operation@juntendo.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

順天堂大学練馬病院(東京都)、東京医科歯科大学病院(東京都)、日本医科大学武蔵小杉病院(神奈川県)、広島市民病院(広島県)


Other administrative information

Date of disclosure of the study information

2023 Year 08 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 05 Month 09 Day

Date of IRB

2023 Year 09 Month 19 Day

Anticipated trial start date

2023 Year 10 Month 03 Day

Last follow-up date

2025 Year 09 Month 06 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

(1) Basic information on study subjects: age, gender, height, weight, major illnesses, alcohol and drug history, medications, Charlson comorbidity index, APACHE II score, ECOG Performance Status score, Clinical Dementia Rating (CDR) score
(2)Observation of delirium: The presence or absence of delirium as defined in DSM-5 will be assessed daily for 7 days. The Delirium Rating Scale-Revised (DRS-R-98) and the Delirium Etiology Rating Checklist will be assessed at the time of enrollment and at the time of reappearance of delirium. The active form of delirium will be recorded at the same time.
(3) Electroencephalography: The electroencephalography will be performed on the day of enrollment. Electrode placement will be noninvasive, with T1 and T2 added to the usual 10-20 method, which can detect the medial temporal lobe as a focus for temporal lobe epilepsy, which frequently occurs in the elderly. The standard reference electrode guidance (earlobe electrode), bipolar guidance, and AV methods are used for derivation. For waveforms that are difficult to determine with these derivation methods, derivation using the temporal region on the opposite side of the spine wave as a reference is used (noninvasive). The standard recording time is 30 minutes, and if the patient does not transition to a sleep EEG, the patient should wait until about 1 hour, if possible, before transitioning to sleep. Record whether the patient has transitioned to sleep.


Management information

Registered date

2023 Year 05 Month 07 Day

Last modified on

2023 Year 10 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000058134